Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy

• Published in: ACG case reports journal Vol. 3; no. 1; pp. 69 - 70
• Main Authors: Lim, Lucy Y, La, Danie, Cserti-Gazdewich, Christine M, Shah, Hemant
• Format: Journal Article
• Language: English
• Published: United States American College of Gastroenterology 01-10-2015
• Subjects: Case Report
• ISSN: 2326-3253; 2326-3253
• DOI: 10.14309/crj.2015.104

Epidemiologic studies have suggested an association between hepatitis C virus (HCV) infection and antigendriven lymphoproliferative disorders, in particular marginal zone lymphomas. Antiviral therapy has been shown to exert an anti-lymphoma effect in these indolent B-cell lymphoproliferations, with survival gains observed. However, these protocols have traditionally incorporated interferon. We describe a patient with chronic hepatitis C, immune thrombocytopenia, and splenic marginal zone lymphoma who, after eradication of HCV with sofosbuvir and ribavirin, exhibited complete remission of both hematologic conditions. With the numerous new potent drugs currently available, the future looks positive with highly efficacious interferon-free regimens for HCV therapy.